CARTICEL is the first and only FDA-approved cell therapy product used to repair articular cartilage injuries in the knee of adults who have not responded to a prior arthroscopic or other surgical repair procedure.

CARTICEL is the only treatment that uses a patient's own cells to repair cartilage injuries in the knee. CARTICEL is implanted in a surgical procedure called autologous chondrocyte implantation or ACI. The implanted cells can form new hyaline-like cartilage, with properties similar to normal cartilage which may reduce pain and improve knee function.